Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ELCC 2019 1000x250

Media registration

The ELCC organisers welcome media interested in obtaining information and reporting on cancer issues. Registration is free to bona fide journalists on presentation of a letter of assignment and a valid press card. Media representatives are required to observe and abide by the ELCC Media Policy which applies to all ELCC editions.

Complete the Media Registration Form

Media registration in advance is strongly recommended although on-site registration will still be possible. Further information for press representatives will be made available over the following weeks. Please contact the ELCC Press Office for any additional questions.

Publication schedule for accepted abstracts

  1. Abstracts accepted for presentation at ELCC 2019 as Proffered Paper, Mini Oral and Poster will be published online on the ESMO website at 12:00 CEST on Wednesday, 3 April 2019.
  2. Late-breaking abstracts will be made public at the start of the official Congress session during which they are presented.

Press programme

Following abstracts are included in the ELCC Press Programme and will be accompanied by a press release.

Please note that for 103O_PR and 169P_PR the publication schedule differs from the general one posted above.

Upon publication, direct link to the press releases will be added.



First author name

Embargo lift and press release distribution date/time

Press release


Safety and efficacy of pembrolizumab (Pembro) monotherapy in elderly patients (Pts) with PD-L1–positive advanced NSCLC: Pooled analysis from KEYNOTE-010, -024, and -042

K. Nosaki

Wednesday, 10 April 2019 at 00:05 CEST


Benefit of immunotherapy (IT) in advanced non-small cell lung cancer (NSCLC) in elderly patients (EP)

E. Corral de la Fuente


Mutational Landscape of Metastatic Cancers Discovered from Prospective Clinical Sequencing at Community Practice Cancer Program.

T.K. Owonikoko

Thursday, 11 April 2019 at 14:45 CEST

Third-party media activities

Media activities initiated by third parties during or in connection with , including, but not limited to:

  • Meetings such as press conferences, media briefings, educational sessions for media representatives, as well as
  • PR activities, such as press releases, news, articles, interviews, etc.

are subject to the ELCC Policy on Third-Party Media Activities.

This policy aims to guarantee proper and correct distribution of oncology and cancer-related information to media representatives in connection with the conference.

Press events in or outside the congress centre but concomitant with/or during breaks of the scientific programme of ELCC 2019 are subject to ELCC Press Office approval.

Please submit your first request through the following form.

Blackout times

During Blackout times any media activity initiated by third parties is not allowed.



10 April 2019


11 April 2019


12 April 2019


13 April 2019



ELCC Press Office

E-mail: media@esmo.org

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings